Work

Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus

Year: 2011

Type: article

Source: The Journal of Clinical Endocrinology & Metabolism

DOI: 10.1210/jc.2011-0666

Authors: James C. Yao, Marianne Pavel, Alexandria T. Phan, Matthew H. Kulke, Sakina Hoosen, Jessica St. Peter, Azzeddine Cherfi, Kjell E. Öberg

Institutions: The University of Texas MD Anderson Cancer Center, Charité – Universitätsmedizin Berlin, Dana-Farber Cancer Institute, Novartis (United States), Novartis (Switzerland), Uppsala University Hospital

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Novartis Pharmaceuticals Corporation, Ipsen, Novartis Pharma

OpenAlex ID: W2163537725

FWCI: 15.67

Cites: 33

Cited by: 226

Related to: 10